Table 2.
Variable | 3 weeks | p value | 20 weeks | p value | ||
---|---|---|---|---|---|---|
HFD (n = 8) |
CD (n = 7) |
HFD (n = 18) |
CD (n = 13) |
|||
Sex (female) | 4 (50%) | 4 (57.1%) | 0.782 | 11 (61.1%) | 7 (53.8%) | 0.686 |
Body weight (g) | 21.3 ± 2.61 | 18.9 ± 2.25 | 0.083 | 39.50 ± 7.38 | 28.06 ± 3.79 | < 0.001*** |
Body length (cm) | 8.65 ± 0.35 | 8.36 ± 0.42 | 0.160 | 9.27 ± 0.30 | 8.87 ± 0.32 | < 0.001*** |
BMI (kg/m2) | 28.38 ± 2.33 | 27.14 ± 2.61 | 0.351 | 45.82 ± 7.11 | 35.69 ± 3.40 | < 0.001*** |
Total cholesterol (mg/dL) | 141.50 ± 17.53 | 86.14 ± 10.75 | < 0.001*** | 168.22 ± 43.45 | 85.69 ± 11.71 | < 0.001*** |
HDL (mg/dL) | 98.14 ± 13.93 | 59.43 ± 6.05 | < 0.001*** | 111.78 ± 25.19 | 63.69 ± 11.88 | < 0.001*** |
LDL (mg/dL) | 82.03 ± 14.42 | 33.84 ± 9.48 | < 0.001*** | 110.02 ± 36.82 | 36.61 ± 10.05 | < 0.001*** |
Triglycerides (mg/dL) | 110.00 ± 34.65 | 87.14 ± 24.31 | 0.089 | 74.33 ± 22.47 | 69.54 ± 15.93 | 0.516 |
AST (U/L) | 83.60 ± 40.15 | 73.60 ± 28.04 | 0.660 | 247.44 ± 181.57 | 69.44 ± 20.40 | 0.008** |
ALT (U/L) | 57.18 ± 33.68 | 40.20 ± 29.61 | 0.092 | 67.35 ± 31.64 | 46.08 ± 35.41 | 0.047* |
Glucose (mg/dL) | 329.25 ± 26.00 | 307.71 ± 34.04 | 0.188 | 321.94 ± 79.11 | 271.00 ± 35.00 | 0.039* |
Insulin (µU/mL) | 1.33 ± 0.71 | 0.96 ± 0.25 | 0.219 | 2.79 ± 1.88 | 1.22 ± 0.30 | 0.042* |
HOMA-IR | 1.08 ± 0.57 | 0.73 ± 0.22 | 0.162 | 2.38 ± 1.78 | 0.87 ± 0.28 | 0.010** |
Steatosis grade (0/1/2/3) |
75%/25%/ 0/0 |
100%/0/ 0/0 |
0.155 |
5.6%/66.7%/ 16.7%/11.1% |
100%/0/0/0 | < 0.001*** |
Lobular inflammation (0/1/2/3) |
62.5%/25%/ 12.5%/0 |
71.4%/28.6%/ 0/0 |
0.626 |
27.8%/27.8%/ 33.3%/11.1% |
76.9%/23.1%/ 0/0 |
0.022* |
Ballooning (no/yes) | 100%/0 | 100%/0 | – | 93.3%/6.7% | 100%/0 | – |
Data are shown as mean ± SD for continuous variables, number (%) for binary variables, and frequency for categorical variables. T-test was used to test for significant differences with continuous variables. Chi-Square test was used for categorical variables
***p < 0.001, **p < 0.01, *p < 0.05